| Not Yet Recruiting | A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 X-linked Congenital Nephrogenic Diabetes Insipidus | Phase 1 | 2026-06-02 |
| Recruiting | A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepi Healthy Volunteers | Phase 1 | 2026-03-31 |
| Not Yet Recruiting | A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults Schizophrenia | Phase 1 | 2026-03-20 |
| Recruiting | A Trial to Assess How Centanafadine Interacts With Stimulants in the Body ADHD | Phase 1 | 2026-02-05 |
| Recruiting | A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults Incomplete Response - Major Depressive Disorder (IR-MDD) | Phase 1 | 2026-01-15 |
| Recruiting | A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU) Phenylketonuria | Phase 3 | 2025-10-20 |
| Recruiting | A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis Pulmonary Tuberculosis | Phase 3 | 2025-10-16 |
| Recruiting | A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria Phenylketonuria (PKU) | Phase 2 | 2025-07-16 |
| Not Yet Recruiting | A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria Phenylketonuria (PKU) | Phase 3 | 2025-06-01 |
| Withdrawn | A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure Heart Failure | Phase 2 | 2025-04-30 |
| Active Not Recruiting | A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjogren Disease | Phase 2 | 2025-04-23 |
| Active Not Recruiting | P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety ADHD, Anxiety, Generalized Anxiety | Phase 3 | 2025-03-26 |
| Recruiting | A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity o Systemic Lupus Erythematosus (SLE), Alopecia Areata (AA), Immune-mediated Focal Segmental Glomerulosclerosis (FSGS) | Phase 1 | 2025-03-17 |
| Completed | A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women Schizophrenia | Phase 1 | 2025-03-07 |
| Recruiting | A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia Schizophrenia | Phase 3 | 2025-02-28 |
| Recruiting | Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue IgA Nephropathy | Phase 2 | 2024-11-19 |
| Completed | A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand Attention Deficit Disorder With Hyperactivity | Phase 1 | 2024-08-29 |
| Completed | A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men Healthy Volunteers | Phase 1 | 2023-11-20 |
| Completed | A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Healthy, Plaque Psoriasis | Phase 1 | 2023-08-21 |
| Completed | A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion Mental Disorder, Schizophrenia, Major Depressive Disorder | N/A | 2023-06-26 |
| Completed | A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia Schizophrenia | Phase 1 | 2023-06-21 |
| Completed | An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-3638 Schizophrenia | Phase 3 | 2023-03-31 |
| Completed | A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anx Generalized Anxiety Disorder | Phase 2 / Phase 3 | 2023-03-08 |
| Completed | Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subj Healthy Adult Participants | Phase 1 | 2023-03-08 |
| Recruiting | A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Autosomal Recessive Polycystic Kidney (ARPKD) | Phase 3 | 2023-01-23 |
| Completed | A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia Schizophrenia | Phase 3 | 2022-12-19 |
| Completed | A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Bod Schizophrenia | Phase 1 | 2022-11-15 |
| Completed | A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2022-11-09 |
| Active Not Recruiting | First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Pheny Phenylketonuria | Phase 1 / Phase 2 | 2022-10-31 |
| Completed | A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of C Healthy Volunteers | Phase 1 | 2022-10-27 |
| Completed | Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressiv Major Depressive Disorder | Phase 2 | 2022-09-12 |
| Terminated | A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Se Post-traumatic Stress Disorder (PTSD) | Phase 1 | 2022-09-07 |
| Completed | A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Gl Schizophrenia | Phase 1 | 2022-08-30 |
| Withdrawn | Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety Major Depressive Disorder (MDD) | Phase 4 | 2022-08-29 |
| Completed | A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD) Attention Deficit/Hyperactivity Disorder | Phase 3 | 2022-07-11 |
| Withdrawn | A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less T Autosomal Recessive Polycystic Kidney Disease (ARPKD) | Phase 3 | 2022-07-01 |
| Completed | A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subje Schizophrenia | Phase 1 | 2022-06-13 |
| Completed | A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease) Autoimmune Diseases | Phase 1 | 2022-04-28 |
| Completed | Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants Wit Pulmonary TB | Phase 2 | 2022-04-12 |
| Enrolling By Invitation | Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy Immunoglobulin A Nephropathy | Phase 2 / Phase 3 | 2022-04-05 |
| Active Not Recruiting | Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) Immunoglobulin A Nephropathy | Phase 3 | 2022-03-15 |
| Active Not Recruiting | A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Dis Attention Deficit/Hyperactivity Disorder | Phase 3 | 2022-02-24 |
| Completed | A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder Attention-Deficit/Hyperactivity Disorder | Phase 3 | 2022-02-02 |
| Completed | A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder Binge-Eating Disorder | Phase 2 | 2021-12-22 |
| Completed | Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment Smoking Cessation | Phase 2 | 2021-09-15 |
| Completed | A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Schizophrenia | Phase 1 | 2021-05-12 |
| Completed | Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder Major Depressive Disorder | Phase 4 | 2021-04-01 |
| Completed | A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjec Attention-deficit Hyperactivity Disorder | Phase 1 | 2021-03-09 |
| Completed | Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disord Major Depressive Disorder | N/A | 2021-02-25 |
| Terminated | Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients W Agitation in Patients With Dementia of the Alzheimer's Type | Phase 3 | 2020-09-11 |
| Terminated | Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients Wit Agitation in Patients With Dementia of the Alzheimer's Type | Phase 3 | 2020-07-13 |
| Completed | A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults Schizophrenia | Phase 1 | 2020-06-18 |
| Completed | A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With A Attention Deficit Hyperactivity Disorder | Phase 1 | 2020-06-11 |
| Terminated | Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammat Crohn's Disease | Phase 2 | 2020-02-25 |
| Completed | A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-2 Epilepsy | Phase 1 | 2020-02-18 |
| Completed | Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disor Irritability Associated With Autism Spectrum Disorder | Phase 3 | 2020-01-23 |
| Completed | Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Borderline Personality Disorder | Phase 2 / Phase 3 | 2020-01-13 |
| Completed | A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. Schizophrenia | Phase 3 | 2019-11-21 |
| Terminated | A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With S Schizophrenia | Phase 3 | 2019-11-20 |
| Completed | Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disor Irritability Associated With Autism Spectrum Disorder (ASD) | Phase 3 | 2019-10-30 |
| Completed | Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Dis Post Traumatic Stress Disorder | Phase 3 | 2019-10-30 |
| Completed | A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder Borderline Personality Disorder | Phase 2 | 2019-10-17 |
| Completed | Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD Post Traumatic Stress Disorder | Phase 3 | 2019-10-17 |
| Completed | Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Ped Attention Deficit Hyperactivity Disorder | Phase 2 | 2019-10-07 |
| Completed | A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic Peopl Schizophrenia | Phase 3 | 2019-09-30 |
| Completed | A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia | Phase 3 | 2019-09-11 |
| Completed | A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychot Schizophrenia | Phase 1 | 2019-08-07 |
| Completed | A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder Schizophrenia, Bipolar I Disorder | Phase 1 / Phase 2 | 2019-08-01 |
| Terminated | A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® Schizophrenia | Phase 3 | 2019-04-29 |
| Completed | Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar D Bipolar Disorder, Schizophrenia | Phase 1 | 2019-03-27 |
| Terminated | Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia Schizophrenia | Phase 2 / Phase 3 | 2019-02-15 |
| Completed | A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder | Phase 3 | 2019-02-14 |
| Completed | A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disord Schizophrenia, Bipolar I Disorder | Phase 1 | 2019-01-31 |
| Completed | A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults W Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder | Phase 3 | 2019-01-16 |
| Completed | A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adult Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder | Phase 3 | 2019-01-16 |
| Completed | A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis Pulmonary TB | Phase 1 / Phase 2 | 2018-10-18 |
| Terminated | Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder (TD) | Phase 4 | 2018-10-13 |
| Completed | A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subject Alzheimer's Disease | Phase 3 | 2018-10-11 |
| Completed | A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adult Major Depressive Disorder | Phase 3 | 2018-07-13 |
| Terminated | A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Schizophrenia, Bipolar 1 Disorder, Major Depressive Disorder | Phase 4 | 2018-06-28 |
| Completed | A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals Schizophrenia, Schizoaffective Disorder, First Episode Psychosis | Phase 4 | 2018-05-21 |
| Completed | A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated W Agitation Associated With Alzheimer's Dementia, Alzheimer Dementia | Phase 3 | 2018-05-16 |
| Terminated | Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Intermittent Explosive Disorder | Phase 2 | 2018-01-18 |
| Completed | The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder Adult Attention Deficit Hyperactivity Disorder | Phase 2 | 2017-11-09 |
| Completed | A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar Bipolar I Disorder, Acute Mania | Phase 3 | 2017-10-24 |
| Completed | Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quin Agitation in Patients With Dementia of the Alzheimer's Type | Phase 3 | 2017-10-13 |
| Completed | Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years O ADHD, Autism, Bipolar I Disorder | Phase 1 | 2017-10-10 |
| Completed | A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipo Bipolar I Disorder, Manic Episode | Phase 3 | 2017-09-19 |
| Completed | A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipol Bipolar I Disorder, Manic Episode | Phase 3 | 2017-09-14 |
| Completed | Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia | Phase 3 | 2017-08-23 |
| Completed | Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescent Schizophrenia | Phase 3 | 2017-06-30 |
| Completed | Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia Schizophrenia | Phase 1 | 2017-06-14 |
| Completed | Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhi Neurobehavioral Disinhibition | Phase 2 | 2017-05-30 |
| Completed | An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia Schizophrenia | Phase 2 | 2017-01-31 |
| Completed | A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With P Stress Disorders, Post-Traumatic | Phase 2 | 2017-01-26 |
| Terminated | Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophre Schizophrenia | Phase 1 | 2017-01-01 |
| Completed | A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease P Parkinson Disease Psychosis | Phase 2 | 2016-12-31 |
| Completed | A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia Schizophrenia | Phase 2 | 2016-12-05 |
| Completed | Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autos Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 | 2016-09-23 |
| Terminated | An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euv Hyponatremia | Phase 3 | 2016-04-22 |
| Completed | Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System Schizophrenia, Major Depressive Disorder, Bipolar I Disorder | Phase 2 | 2016-03-01 |
| Terminated | A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Si Adult Attention-deficit Hyperactivity Disorder (ADHD) | Phase 1 | 2015-12-01 |
| Terminated | Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients Wi Agitation in Patients With Dementia of the Alzheimer's Type | Phase 3 | 2015-11-13 |
| Completed | Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of Agitation in Participants With Dementia of the Alzheimer's Type | Phase 3 | 2015-11-11 |
| Withdrawn | A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia Hyponatremia | Phase 3 | 2015-11-01 |
| Terminated | Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hyp Hyponatremia | Phase 3 | 2015-09-22 |
| Completed | Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperac Attention Deficit Disorder With Hyperactivity | Phase 2 | 2015-08-03 |
| Completed | Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the A Agitation in Patients With Dementia of the Alzheimer's Type | Phase 3 | 2015-07-23 |
| Completed | Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescent Schizophrenia | Phase 1 | 2015-03-01 |
| Completed | Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity Schizophrenia With Impulsivity | Phase 3 | 2015-02-01 |
| Completed | Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 ( Device Latency | Phase 4 | 2015-02-01 |
| Completed | Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Polycystic Kidney, Autosomal Dominant | Phase 3 | 2014-10-17 |
| Withdrawn | Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability Major Depressive Disorder and Irritability | Phase 3 | 2014-09-01 |
| Completed | Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizo Schizophrenia, Mental Disorder, Nervous System Diseases | Phase 2 | 2014-08-01 |
| Completed | Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatmen Depressive Disorder, Depression, Depressive Disorder, Major | Phase 3 | 2014-07-01 |
| Completed | A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atop Atopic Dermatitis | Phase 2 | 2014-06-20 |
| Completed | This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in Peopl Narcolepsy | Phase 1 | 2014-06-05 |
| Completed | Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previo Agitation Associated With Alzheimer's Disease, Alzheimer's Type, Mental Disorder | — | 2014-06-01 |
| Completed | Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Chronic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease | Phase 3 | 2014-05-01 |
| Completed | A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users Healthy Volunteers, Drug Users | Phase 1 | 2014-05-01 |
| Completed | Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND Device Latency | Phase 4 | 2014-03-21 |
| Completed | Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics Schizophrenia | Phase 1 | 2014-03-01 |
| Withdrawn | Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects Bipolar 1 Disorder, Schizophrenia, Mental Disorder | Phase 2 | 2014-03-01 |
| Completed | Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia Schizophrenia | Phase 3 | 2014-02-01 |
| Completed | A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Drug-drug Interaction | Phase 1 | 2014-01-01 |
| Completed | Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar Bipolar 1 Disorder, Schizophrenia, Mental Disorder | — | 2013-12-01 |
| Completed | Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia Schizophrenia | Phase 3 | 2013-11-01 |
| Completed | Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressi MDD | Phase 3 | 2013-11-01 |
| Completed | Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symp Major Depressive Disorder, Anxiety | Phase 3 | 2013-11-01 |
| Completed | Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adju Major Depressive Disorder (MDD) | Phase 3 | 2013-11-01 |
| Completed | A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) | Phase 1 / Phase 2 | 2013-11-01 |
| Completed | Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Ad Adult ADHD | Phase 2 | 2013-10-03 |
| Completed | Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia | Phase 1 | 2013-10-01 |
| Completed | PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia Schizophrenia | Phase 1 | 2013-09-01 |
| Completed | Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Agitation Associated With, Alzheimer's Disease, Alzheimer's Type | Phase 3 | 2013-09-01 |
| Completed | A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects Wit Schizophrenia | Phase 1 | 2013-08-01 |
| Completed | A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidr Multidrug Resistant Tuberculosis | Phase 2 | 2013-07-20 |
| Completed | A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Agitation Associated With, Alzheimer's Disease, Alzheimer's Type | Phase 3 | 2013-07-11 |
| Completed | Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia Schizophrenia, Mental Disorder, Nervous System Diseases | Phase 1 | 2013-07-01 |
| Completed | Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resis Multidrug Resistant Tuberculosis, Pediatric | Phase 1 | 2013-06-14 |
| Completed | A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation Normal, Healthy Volunteers | Phase 1 | 2013-02-01 |
| Completed | Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schiz Schizophrenia | Phase 3 | 2013-01-01 |
| Completed | Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Tourette's Disorder, Tic Disorder | Phase 3 | 2013-01-01 |
| Completed | A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Depressive Disorder, Depression, Depressive Disorder, Major | Phase 3 | 2012-12-01 |
| Completed | Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Bipolar I | Phase 3 | 2012-11-01 |
| Completed | Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescent Tourette's Disorder, Tic Disorder | Phase 3 | 2012-11-01 |
| Completed | Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizo Schizophrenia | Phase 3 | 2012-10-01 |
| Completed | Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizo Acute Schizophrenia | Phase 3 | 2012-10-01 |
| Completed | A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermati Atopic Dermatitis | Phase 1 | 2012-08-01 |
| Completed | Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Bipolar I Disorder | Phase 3 | 2012-08-01 |
| Completed | Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects Wit Major Depressive Disorder | Phase 1 | 2012-07-01 |
| Completed | A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-1 Solid Tumors | Phase 1 | 2012-06-01 |
| Completed | An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia Schizophrenia | Phase 1 | 2012-05-01 |
| Completed | Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabiliz Schizophrenia | Phase 1 | 2012-01-01 |
| Terminated | Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics V Schizophrenia | Phase 3 | 2012-01-01 |
| Terminated | Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fib Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | Phase 1 | 2011-11-01 |
| Completed | Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Dis Tourette's Disorder | Phase 3 | 2011-10-19 |
| Completed | Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Depressive Disorder, Depression, Depressive Disorder, Major | Phase 3 | 2011-10-01 |
| Completed | 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Autosomal Dominant Polycystic Kidney Disease | Phase 2 | 2011-10-01 |
| Completed | Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis Multidrug-resistant Tuberculosis | Phase 3 | 2011-09-02 |
| Completed | Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics V Schizophrenia | Phase 3 | 2011-09-01 |
| Completed | Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Schizophrenia | Phase 3 | 2011-09-01 |
| Completed | Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Tourette's Disorder | Phase 3 | 2011-08-02 |
| Completed | Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Tourette's Disorder | Phase 3 | 2011-07-27 |
| Completed | Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Depressive Disorder, Depression, Depressive Disorder, Major | Phase 3 | 2011-07-01 |
| Completed | Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizop Acute Schizophrenia | Phase 3 | 2011-07-01 |
| Completed | Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia Schizophrenia | Phase 3 | 2011-07-01 |
| Completed | Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorde Schizophrenia, Schizoaffective Disorder | Phase 1 | 2011-07-01 |
| Completed | Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia Acute Schizophrenia | Phase 3 | 2011-07-01 |
| Completed | Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease Autosomal Dominant Polycystic Kidney Disease (ADPKD) | — | 2011-06-01 |
| Completed | Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adu Depressive Disorder, Depression, Depressive Disorder, Major | Phase 3 | 2011-06-01 |
| Completed | Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2011-06-01 |
| Completed | Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD) Depressive Disorder, Major | — | 2011-01-01 |
| Completed | Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects Schizophrenia, Psychiatric Disorders | Phase 1 | 2011-01-01 |
| Completed | A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects Schizophrenia | Phase 1 | 2010-12-01 |
| Terminated | To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants Major Depressive Disorder (MDD) | Phase 3 | 2010-11-18 |
| Terminated | Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Thera Major Depressive Disorder (MDD) | Phase 3 | 2010-10-04 |
| Terminated | Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia Hyponatremia, Dilutional Hyponatremia, Inappropriate ADH Syndrome | Phase 3 | 2010-10-01 |
| Completed | Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Diseas Autosomal Dominant Polycystic Kidney Disease | Phase 2 | 2010-10-01 |
| Completed | Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD Autosomal Dominant Polycystic Kidney Disease | Phase 2 | 2010-10-01 |
| Terminated | Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Thera Major Depressive Disorder (MDD) | Phase 3 | 2010-07-29 |
| Terminated | Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Thera Major Depressive Disorder (MDD) | Phase 3 | 2010-07-13 |
| Terminated | Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bip Adolescent Schizophrenia, Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features | Phase 3 | 2010-07-01 |
| Completed | An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia | Phase 3 | 2010-06-24 |
| Completed | Tolvaptan Extension Study in Participants With ADPKD Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 | 2010-05-26 |
| Completed | IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myelom Multiple Myeloma | Phase 2 | 2010-05-01 |
| Completed | Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention D Attention Deficit Hyperactivity Disorder | Phase 2 | 2010-03-16 |
| Completed | Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depr Major Depressive Disorder | Phase 2 | 2010-03-01 |
| Terminated | Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis Tuberculosis | Phase 2 | 2010-02-19 |
| Completed | Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer Advanced Cancer | Phase 1 | 2010-02-01 |
| Completed | PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphom Lymphoma | Phase 2 | 2010-01-01 |
| Completed | Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major De Major Depressive Disorder | Phase 2 | 2009-09-01 |
| Completed | Multicenter, Open-label, Safety and Tolerability Study Schizophrenia | Phase 2 | 2009-08-01 |
| Completed | Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of A Schizophrenia | Phase 2 | 2009-07-01 |
| Completed | The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use Depressive Disorder, Major | — | 2009-06-01 |
| Completed | Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major De Major Depressive Disorder | Phase 2 | 2009-05-01 |
| Completed | Outcomes in MEasurement-Based Treatment Depressive Disorder, Major | — | 2009-05-01 |
| Terminated | Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients Schizophrenia, Schizoaffective Disorder, Bipolar I Disorder | Phase 3 | 2009-04-01 |
| Completed | A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 Tuberculosis, Multidrug-Resistant | Phase 2 | 2009-03-26 |
| Terminated | Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema Chronic Obstructive Pulmonary Disease | Phase 2 | 2009-03-01 |
| Completed | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia Schizophrenia | Phase 3 | 2008-12-01 |
| Completed | Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712 Schizophrenia | Phase 1 | 2008-12-01 |
| Completed | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia Schizophrenia | Phase 3 | 2008-09-01 |
| Completed | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia Schizophrenia | Phase 3 | 2008-07-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks Bipolar Disorder Mania | Phase 3 | 2008-06-01 |
| Completed | A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tube Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis | Phase 2 | 2008-05-08 |
| Completed | A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Schizophrenia | Phase 1 | 2007-11-01 |
| Completed | Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Dis Depressive Disorder, Major | — | 2007-10-01 |
| Completed | Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremia | Phase 3 | 2007-08-01 |
| Completed | Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Polycystic Kidney Disease, Autosomal Dominant | Phase 3 | 2007-01-01 |
| Withdrawn | A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode Bipolar Disorder | Phase 3 | 2006-12-01 |
| Completed | Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autisti Autistic Disorder, Behavioral Symptoms | Phase 3 | 2006-09-01 |
| Completed | Aripiprazole and Lexapro Drug Interaction Study Healthy | Phase 1 | 2006-08-01 |
| Completed | Aripiprazole and Effexor XR Drug Interaction Study Healthy | Phase 1 | 2006-08-01 |
| Completed | Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder Bipolar Disorder | Phase 1 | 2006-07-01 |
| Completed | Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaff Schizophrenia, Schizoaffective Disorder | Phase 4 | 2006-07-01 |
| Completed | Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) Behavioral Symptoms, Autistic Disorder | Phase 3 | 2006-06-01 |
| Completed | Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) Autistic Disorder | Phase 3 | 2006-06-01 |
| Completed | Oral Aripiprazole Open-Label Rollover Study Schizophrenia | Phase 3 | 2006-04-01 |
| Completed | A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients Schizophrenia | Phase 4 | 2005-12-01 |
| Completed | A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term M Bipolar Disorder | Phase 4 | 2005-12-01 |
| Completed | Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Di Polycystic Kidney, Autosomal Dominant | Phase 2 | 2005-12-01 |
| Completed | A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania Bipolar Disorder | Phase 4 | 2005-09-01 |
| Completed | A Switch Study of BMS-337039 in Schizophrenic Out-patients Schizophrenia | Phase 4 | 2005-06-01 |
| Completed | Effect on Cognitive Function of a Treatment With Aripiprazole Schizophrenia | Phase 4 | 2005-03-01 |
| Completed | A Study of Aripiprazole in Patients With Major Depressive Disorder Major Depressive Disorder | Phase 3 | 2005-03-01 |
| Completed | Aripiprazole in Children and Adolescents With Bipolar I Disorder Bipolar Disorder | Phase 3 | 2005-03-01 |
| Completed | A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices Schizophrenia and Schizoaffective Disorder | Phase 3 | 2005-03-01 |
| Completed | Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure Heart Failure, Congestive | Phase 2 | 2004-12-01 |
| Completed | Study of Aripiprazole in Patients With Acute Bipolar Mania Bipolar Disorder | Phase 3 | 2004-12-01 |
| Completed | Study of Aripiprazole in Patients With Bipolar I Disorder Bipolar Disorder | Phase 3 | 2004-10-01 |
| Completed | A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder Major Depressive Disorder | Phase 3 | 2004-09-01 |
| Completed | Aripiprazole Open-Label, Safety and Tolerability Study Schizophrenia, Bipolar Disorder | Phase 3 | 2004-09-01 |
| Completed | Schizophrenia Trial of Aripiprazole Schizophrenia | Phase 3 | 2004-07-01 |
| Completed | Aripiprazole in Adolescents With Schizophrenia Schizophrenia | Phase 3 | 2004-07-01 |
| Completed | Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents Schizophrenia, Mania | Phase 2 | 2004-07-01 |
| Completed | Aripiprazole in Patients With Acute Mania Bipolar Disorder | Phase 3 | 2004-06-01 |
| Completed | A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode Bipolar I Disorder | Phase 3 | 2004-06-01 |
| Completed | CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission Ulcerative Colitis | Phase 3 | 2004-05-01 |
| Completed | International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Pa Hyponatremia | Phase 3 | 2004-05-01 |
| Completed | Study of Rebamipide Eye Drops to Treat Dry Eye Keratoconjunctivitis Sicca | Phase 3 | 2004-05-01 |
| Completed | Study of Rebamipide Eye Drops to Treat Dry Eye Keratoconjunctivitis Sicca | Phase 3 | 2004-05-01 |
| Completed | Study of Aripiprazole in Subjects With Alcoholism Alcoholism | Phase 4 | 2004-04-01 |
| Completed | Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Di Body Weight Change, Schizophrenia, Schizoaffective Disorder | Phase 3 | 2004-03-01 |
| Completed | Aripiprazole Oral Acceptability Trial Schizophrenia | Phase 3 | 2004-03-01 |
| Completed | Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode Bipolar Disorder | Phase 3 | 2004-01-01 |
| Completed | Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia Dementia, Alzheimer's Disease | Phase 3 | 2003-12-01 |
| Completed | "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia Hyponatremia, Water Intoxication, Inappropriate ADH Syndrome | Phase 3 | 2003-11-01 |
| Completed | Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia Schizophrenia | Phase 4 | 2003-11-01 |
| Completed | EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan Congestive Heart Failure | Phase 3 | 2003-09-01 |
| Completed | Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease Parkinson's Disease, Psychoses | Phase 4 | 2003-07-01 |
| Completed | FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerativ Ulcerative Colitis | Phase 3 | 2003-05-01 |
| Completed | FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerati Ulcerative Colitis | Phase 3 | 2003-05-01 |
| Completed | "SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia Hyponatremias, Water Intoxication, Inappropriate ADH Syndrome | Phase 3 | 2003-04-01 |
| Completed | Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials Schizophrenia | Phase 3 | 2003-03-01 |
| Completed | A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices Schizophrenia | Phase 3 | 2002-09-01 |
| Completed | Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Congestive Heart Failure | Phase 2 | 2002-07-01 |
| Completed | Broad Effectiveness: Study With Aripiprazole Schizophrenia, Schizoaffective Disorder | Phase 3 | 2002-07-01 |
| Completed | Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder Bipolar I Disorder | Phase 3 | 2002-06-01 |
| Completed | Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients Congestive Heart Failure | Phase 2 | 2002-05-01 |
| Completed | Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders Schizophrenia | Phase 2 / Phase 3 | 2002-04-01 |
| Completed | Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder Bipolar Disorder | Phase 3 | 2002-02-01 |
| Completed | Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type Dementia, Alzheimer Type | Phase 3 | 2000-08-01 |
| Completed | Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia Schizophrenia | Phase 3 | 2000-06-01 |
| Completed | Study of Aripiprazole in Patients With a History of Bipolar Disorder Bipolar Disorder | Phase 3 | 2000-03-01 |
| Completed | Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Alzheimer Disease | Phase 3 | 2000-03-01 |
| Completed | Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Alzheimer Disease | Phase 3 | 2000-01-01 |
| Terminated | A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia Schizophrenia | Phase 3 | 1998-04-01 |